ATE287953T1 - Persephin und verwandte wachstumsfaktoren - Google Patents

Persephin und verwandte wachstumsfaktoren

Info

Publication number: ATE287953T1
Authority: AT; Austria
Prior art keywords: persephin; methods; growth factors; mouse; neurturin
Prior art date: 1996-03-14

Application number

AT97917509T

Other languages

English (en)

Inventor

Eugene M Johnson Jr

Jeffrey D Milbrandt

Paul T Kotzbauer

Patricia A Lampe

Original Assignee

Univ Washington

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-14

Filing date

1997-03-14

Publication date

2005-02-15

1997-03-14 Application filed by Univ Washington filed Critical Univ Washington

2005-02-15 Application granted granted Critical

2005-02-15 Publication of ATE287953T1 publication Critical patent/ATE287953T1/de

Links

102100036660 Persephin Human genes 0.000 title abstract 5
108010070453 persephin Proteins 0.000 title abstract 5
239000003102 growth factor Substances 0.000 title abstract 4
238000000034 method Methods 0.000 abstract 4
230000010558 Gene Alterations Effects 0.000 abstract 1
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 abstract 1
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 abstract 1
101001136669 Mus musculus Persephin Proteins 0.000 abstract 1
102100021584 Neurturin Human genes 0.000 abstract 1
108010015406 Neurturin Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
101001136668 Rattus norvegicus Persephin Proteins 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
239000002299 complementary DNA Substances 0.000 abstract 1
230000003412 degenerative effect Effects 0.000 abstract 1
238000012544 monitoring process Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Cardiology (AREA)
Gastroenterology & Hepatology (AREA)
Hospice & Palliative Care (AREA)
Zoology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT97917509T 1996-03-14 1997-03-14 Persephin und verwandte wachstumsfaktoren ATE287953T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US61594496A	1996-03-14	1996-03-14
PCT/US1997/003461 WO1997033911A1 (en)	1996-03-14	1997-03-14	Persephin and related growth factors

Publications (1)

Publication Number	Publication Date
ATE287953T1 true ATE287953T1 (de)	2005-02-15

Family

ID=24467424

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97917509T ATE287953T1 (de)	1996-03-14	1997-03-14	Persephin und verwandte wachstumsfaktoren

Country Status (10)

Country	Link
US (4)	US6232449B1 (de)
EP (1)	EP0886651B1 (de)
JP (1)	JP2000507813A (de)
AT (1)	ATE287953T1 (de)
AU (1)	AU716846B2 (de)
CA (1)	CA2225913A1 (de)
DE (1)	DE69732350T2 (de)
ES (1)	ES2237793T3 (de)
NZ (1)	NZ329482A (de)
WO (1)	WO1997033911A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5739307A (en) *	1995-08-28	1998-04-14	Washington University	Polynucleotide encoding neurturin neurotrophic factor
US6716600B1 (en) *	1996-03-14	2004-04-06	Washington University	Persephin and related growth factors
DE69732350T2 (de) *	1996-03-14	2005-12-22	Washington University	Persephin und verwandte wachstumsfaktoren
US6222022B1 (en) *	1996-03-14	2001-04-24	Washington University	Persephin and related growth factors
DE19816186A1 (de) *	1998-04-14	1999-10-21	Univ Muenchen L Maximilians	GDNF-kodierende DNA, Teile davon und GDNF-Varianten
WO2000006731A2 (en) *	1998-07-31	2000-02-10	Washington University	PERSEPHIN ARF, A PROTEIN ENCODED BY UNSPLICED PERSEPHIN mRNA
PL346298A1 (en) *	1998-08-21	2002-01-28	Hannu Sariola	The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
US6284540B1 (en) *	1998-09-29	2001-09-04	Washington University	Artemin, a novel neurotrophic factor
FI991197A0 (fi) *	1999-05-27	1999-05-27	Mart Saarma	Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa
US6866851B1 (en) *	1999-12-28	2005-03-15	Washington University	GFRα1-RET specific agonists and methods therefor
FI20000403A0 (fi) *	2000-02-22	2000-02-22	Hannu Sariola	GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
WO2010144696A1 (en)	2009-06-11	2010-12-16	Burnham Institute For Medical Research	Directed differentiation of stem cells
US9821026B2 (en) *	2012-06-28	2017-11-21	Instituto De Medicina Molecular	Use of RET agonist molecules for haematopoietic stem cell expansion protocols and transplantation therapy and a RET agonist kit

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5141856A (en) *	1989-01-05	1992-08-25	Synergen, Inc.	Expression of purified ciliary neurotrophic factor
US5011914A (en) *	1989-01-05	1991-04-30	Collins Franklin D	Purified ciliary neurotrophic factor
US5260417A (en)	1989-04-03	1993-11-09	Genetics Institute, Inc.	Megakaryocyte growth promoting activity protein
US5235043A (en) *	1990-04-06	1993-08-10	Synergen, Inc.	Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
AU679167B2 (en) *	1991-09-20	1997-06-26	Amgen, Inc.	Glial derived neurotrophic factor
EP0721464A4 (de)	1993-09-01	1998-12-30	Start Technology Partnership	Neuronenregulationsfaktor zur erhöhung der überlebensrate von neuronen
AU1443095A (en) *	1993-12-22	1995-07-10	University Of Medicine And Dentistry Of New Jersey	Novel nucleic acid sequences isolated from glial cells
US5739307A (en) *	1995-08-28	1998-04-14	Washington University	Polynucleotide encoding neurturin neurotrophic factor
DE69732350T2 (de) *	1996-03-14	2005-12-22	Washington University	Persephin und verwandte wachstumsfaktoren

1997
- 1997-03-14 DE DE69732350T patent/DE69732350T2/de not_active Expired - Lifetime
- 1997-03-14 WO PCT/US1997/003461 patent/WO1997033911A1/en not_active Ceased
- 1997-03-14 AT AT97917509T patent/ATE287953T1/de not_active IP Right Cessation
- 1997-03-14 AU AU25804/97A patent/AU716846B2/en not_active Ceased
- 1997-03-14 US US08/981,739 patent/US6232449B1/en not_active Expired - Fee Related
- 1997-03-14 ES ES97917509T patent/ES2237793T3/es not_active Expired - Lifetime
- 1997-03-14 EP EP97917509A patent/EP0886651B1/de not_active Expired - Lifetime
- 1997-03-14 JP JP9532677A patent/JP2000507813A/ja active Pending
- 1997-03-14 NZ NZ329482A patent/NZ329482A/xx unknown
- 1997-03-14 US US09/220,527 patent/US6692943B1/en not_active Expired - Lifetime
- 1997-03-14 CA CA002225913A patent/CA2225913A1/en not_active Abandoned
1998
- 1998-07-31 US US09/128,026 patent/US6403335B1/en not_active Expired - Lifetime
- 1998-12-24 US US09/220,616 patent/US6645937B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU716846B2 (en)	2000-03-09
ES2237793T3 (es)	2005-08-01
EP0886651A4 (de)	2001-01-10
NZ329482A (en)	2000-05-26
CA2225913A1 (en)	1997-09-18
US6645937B1 (en)	2003-11-11
DE69732350T2 (de)	2005-12-22
US6692943B1 (en)	2004-02-17
AU2580497A (en)	1997-10-01
WO1997033911A1 (en)	1997-09-18
DE69732350D1 (de)	2005-03-03
US6403335B1 (en)	2002-06-11
US6232449B1 (en)	2001-05-15
EP0886651B1 (de)	2005-01-26
EP0886651A1 (de)	1998-12-30
JP2000507813A (ja)	2000-06-27

Legal Events

Date	Code	Title	Description
2005-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE315578T1 (de)	2006-02-15	Neuriturin und verwandte wachstumsfaktoren
ATE287953T1 (de)	2005-02-15	Persephin und verwandte wachstumsfaktoren
EP1009768A4 (de)	2002-06-12	Persephin und verwandte wachstumsfaktoren
ATE288447T1 (de)	2005-02-15	Methode zur behandlung von alzheimer mit einem von einer gliazelllinie stammenden neurotrophen protein (gdnf)
DE69913665D1 (de)	2004-01-29	Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
DE69711894D1 (de)	2002-05-16	Lipoxinverbindungen und deren verwendung zur behandlung der zellenwucherungsstörung
AU3472997A (en)	1997-12-09	Ret ligand (retl) for stimulating neural and renal growth
KR920700291A (ko)	1992-02-19	골 유도 조성물
AU1615599A (en)	1999-06-16	Differentiation of adipose stromal cells into osteoblasts and uses thereof
DE69731834D1 (de)	2005-01-05	Agouti verwandtes gen
LV10308A (lv)	1994-10-20	Ciliarais neirotropais faktors
ATE127844T1 (de)	1995-09-15	Dns und ihre verwendung.
NZ335109A (en)	2000-08-25	Stable analogs of keratinocyte growth factor (KRF) useful for preventing alopecia, treating gastro-duodenal ulcers, bowel disease, liver function or general induction epithelial cell proliferation
ATE418999T1 (de)	2009-01-15	Verfahren zur behandlung von multiplem myelom und von myelom- induzierter knochenresorption mit antagonisten der integrin-/rezeptorbindung
ATE267247T1 (de)	2004-06-15	Reagenz und verfahren zur inhibierung der n-ras expression
Wang et al.	1991	Thermolabile adenine adducts and A. cntdot. T base pair substitutions induced by nitrogen mustard analogs in an SV40-based shuttle plasmid
ATE203766T1 (de)	2001-08-15	Teil der intronsequenz des von hippel-lindau(vhl)-gens und seine verwendung zur krankheitsdiagnose
CN103215308A (zh)	2013-07-24	表达重组人fviii的整合质粒、细胞株及其构建方法和应用
ES2012128A6 (es)	1990-03-01	Metodo de tratar plantas con acidos organicos que contienen azufre.
RU2003123108A (ru)	2005-02-27	Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови
DE3687241D1 (de)	1993-01-21	Gewebetumorwachstumsinhibitoren, verfahren zur herstellung und verwendungen.
ATE227998T1 (de)	2002-12-15	Verwendung von substituierten dextranen zur behandlung von schädigungen des nervensystems, und fraktionen mit erhöhtem heparansulfat-gehalt
Wirtz et al.	1990	In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2 (I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
PT990000E (pt)	2005-11-30	Factor 3 de crescimento do tecido conjuntivo
DE10394363D2 (de)	2006-09-21	Neue Chelidonin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von pharmazeutischen Wirkstoffen